• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Re:对心血管系统的药理作用。

Ginsenoside Re: pharmacological effects on cardiovascular system.

机构信息

Section of Cardiology, Internal Medicine, JiShuiTan Hospital, Beijing 100035, China.

出版信息

Cardiovasc Ther. 2012 Aug;30(4):e183-8. doi: 10.1111/j.1755-5922.2011.00271.x. Epub 2011 Apr 1.

DOI:10.1111/j.1755-5922.2011.00271.x
PMID:21884006
Abstract

Ginsenosides are the bioactive constituents of ginseng, a key herb in traditional Chinese medicine. As a single component of ginseng, ginsenoside Re (G-Re) belongs to the panaxatriol group. Many reports demonstrated that G-Re possesses the multifaceted beneficial pharmacological effects on cardiovascular system. G-Re has negative effect on cardiac contractility and autorhythmicity. It causes alternations in cardiac electrophysiological properties, which may account for its antiarrhythmic effect. In addition, G-Re also exerts antiischemic effect and induces angiogenic regeneration. In this review, we first outline the chemistry and the pharmacological effects of G-Re on the cardiovascular system.

摘要

人参皂苷是人参的生物活性成分,是中药中的关键草药。作为人参的单一成分,人参皂苷 Re(G-Re)属于人参三醇组。许多报告表明,G-Re 对心血管系统具有多方面的有益的药理作用。G-Re 对心肌收缩力和自律性有负面影响。它导致心脏电生理特性的改变,这可能是其抗心律失常作用的原因。此外,G-Re 还具有抗缺血作用,并诱导血管生成再生。在这篇综述中,我们首先概述了 G-Re 的化学结构和对心血管系统的药理作用。

相似文献

1
Ginsenoside Re: pharmacological effects on cardiovascular system.人参皂苷 Re:对心血管系统的药理作用。
Cardiovasc Ther. 2012 Aug;30(4):e183-8. doi: 10.1111/j.1755-5922.2011.00271.x. Epub 2011 Apr 1.
2
The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction.大蒜素和胺碘酮对心肌梗死大鼠离体心脏传导系统及逆使用依赖性的影响。
J Ethnopharmacol. 2012 Jun 1;141(2):674-84. doi: 10.1016/j.jep.2011.08.051. Epub 2011 Sep 6.
3
[Inotropic, cardioprotective and antiarrhythmic effects of ginseng preparations].[人参制剂的变力性、心脏保护及抗心律失常作用]
Eksp Klin Farmakol. 2009 Jul-Aug;72(4):52-60.
4
Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives.人参皂苷在心血管疾病中的作用和机制:进展与展望。
Sci China Life Sci. 2016 Mar;59(3):292-8. doi: 10.1007/s11427-016-5007-8. Epub 2016 Jan 21.
5
[Some advances in cardiovascular pharmacology (author's transl)].心血管药理学的一些进展(作者译)
Sheng Li Ke Xue Jin Zhan. 1981 Feb;12(2):97-103.
6
The action of ginsenoside Re on inotropy and chronotropy of isolated atria prepared from guinea pigs.人参皂苷Re对豚鼠离体心房变力性和变时性的作用。
Planta Med. 1996 Aug;62(4):314-6. doi: 10.1055/s-2006-957891.
7
Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats.人参皂苷 Rb3 可改善大鼠心肌缺血再灌注损伤。
Pharm Biol. 2011 Sep;49(9):900-6. doi: 10.3109/13880209.2011.554845. Epub 2011 May 19.
8
Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.(2RS,3SR)-2-氨甲基-2,3,7,8-四氢-2,3,5,8,8-五甲基-6H-呋喃并[2,3-e]吲哚-7-酮盐酸盐(UK-1745)的心血管效应,一种具有血管舒张和抗心律失常特性的新型强心剂。
Arzneimittelforschung. 1998 Mar;48(3):219-31.
9
[The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].新型抗心律失常制剂波尼可的抗心律失常活性及其对心脏传导系统的影响
Farmakol Toksikol. 1990 May-Jun;53(3):57-60.
10
The effects of psychotropic drugs on the cardiovascular system.精神药物对心血管系统的影响。
J Clin Psychiatry. 1982 May;43(5 Pt 2):16-31.

引用本文的文献

1
Unlocking ginsenosides' therapeutic power with polymer-based delivery systems: current applications and future perspectives.利用基于聚合物的递送系统释放人参皂苷的治疗潜力:当前应用与未来展望。
Front Pharmacol. 2025 Jul 10;16:1629803. doi: 10.3389/fphar.2025.1629803. eCollection 2025.
2
Ginseng supplementation and vascular function: a systematic review and meta-analysis of clinical trials.人参补充剂与血管功能:临床试验的系统评价和荟萃分析
BMC Complement Med Ther. 2025 Jul 11;25(1):259. doi: 10.1186/s12906-025-04936-5.
3
Ginsenoside Re inhibits myocardial fibrosis by regulating miR-489/myd88/NF-κB pathway.
人参皂苷Re通过调节miR-489/myd88/NF-κB通路抑制心肌纤维化。
J Ginseng Res. 2023 Mar;47(2):218-227. doi: 10.1016/j.jgr.2021.11.009. Epub 2021 Dec 2.
4
Efficacy and safety of Xinmai'an tablet in treatment of premature ventricular contractions due to coronary heart disease: A protocol for systematic review and meta-analysis.心脉安片治疗冠心病室性早搏的有效性和安全性的系统评价和 Meta 分析方案。
Medicine (Baltimore). 2022 Dec 9;101(49):e32253. doi: 10.1097/MD.0000000000032253.
5
Ginsenoside Rd Promotes Cardiac Repair After Myocardial Infarction by Modulating Monocytes/Macrophages Subsets Conversion.人参皂苷 Rd 通过调节单核细胞/巨噬细胞亚群转化促进心肌梗死后的心脏修复。
Drug Des Devel Ther. 2022 Aug 22;16:2767-2782. doi: 10.2147/DDDT.S377624. eCollection 2022.
6
Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae.阐明人参中生物活性的鼠李糖基人参皂苷的途径及其通过工程酿酒酵母从头高效生产。
Commun Biol. 2022 Aug 2;5(1):775. doi: 10.1038/s42003-022-03740-y.
7
The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis. Ginsenosides 和西洋参果通过肠脑轴促进心理健康的未开发潜力。
Nutrients. 2022 Jun 17;14(12):2523. doi: 10.3390/nu14122523.
8
Bio-guided isolation of plant growth regulators from allelopathic plant-: phyto-selective activities and mechanisms.从化感植物中进行生物导向的植物生长调节剂分离:植物选择活性与机制
RSC Adv. 2018 Apr 12;8(25):13649-13655. doi: 10.1039/c7ra12072a. eCollection 2018 Apr 11.
9
Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.整合代谢组学与网络药理学以探究人参皂苷Re对小鼠放疗损伤的保护作用
Evid Based Complement Alternat Med. 2022 Mar 11;2022:5436979. doi: 10.1155/2022/5436979. eCollection 2022.
10
Ginsenosides in genus and their biosynthesis.人参属中的人参皂苷及其生物合成。
Acta Pharm Sin B. 2021 Jul;11(7):1813-1834. doi: 10.1016/j.apsb.2020.12.017. Epub 2021 Jan 2.